Problems, controversies, and perspectives on the clinical use of interleukin-2.
Gambacorti-Passerini
C
C
University of Wisconsin, Madison.
Sondel
P M
PM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007958:Leukocyte Count / Q000187:drug effects; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D007370:Interferon Type I; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha